Login / Signup

Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement.

Hui-Lei MiaoAi-Lin ZhaoMing-Hui DuanDao-Bin ZhouXin-Xin CaoJian Li
Published in: BMC cancer (2020)
An FEV1 ≤ 55% predicted and a history of pneumothorax at diagnosis indicated a poor prognosis. Cytarabine based regimen may arrest the decline in pulmonary function in LCH patients with pulmonary involvement and improve EFS.
Keyphrases
  • poor prognosis
  • long non coding rna
  • pulmonary hypertension
  • acute myeloid leukemia
  • single cell
  • cell therapy
  • cell cycle
  • stem cells
  • cell proliferation
  • mesenchymal stem cells
  • thoracic surgery